Nvidia powered the tech-led rally as a flurry of trade news bolstered prospects for the AI chip giant. The company once again ...

Shares of Humana Inc. were headed higher in early Wednesday trading, after the health insurer reported first-quarter earnings that rose well above expectations, as costs declined and the exit from ...

Neuronetics, Inc., (NASDAQ: STIM) (the "Company" or "Neuronetics") a vertically integrated, commercial stage, medical technology and healthcare company ...

Humana’s dental insurance network has 200,000 providers. Investopedia staff editors and researchers work on behalf of consumers, not insurance companies. For every financial product review we ...

Humana's HUM +1.79% + Free Alerts short percent of float has fallen 14.71% since its last report. The company recently reported that it has 3.12 million shares sold short, which is 2.9% of all regular ...

Reports 1Q25 earnings per share (EPS ... 90.1 percent to 90.5 percent Affirms expected individual Medicare Advantage annual membership decline of approximately 550,000, inclusive of the impact ...

CVS unit Aetna, Elevance and Humana paid brokers eHealth ... have been rising about predatory behavior from the salesmen amid reports that some have been steering beneficiaries to certain plans ...

Humana beat first-quarter profit and sales estimates as it reduced costs and exited some Medicare Advantage plans.

We will begin this morning with brief remarks from Jim Rechtin, Humana's President and Chief Executive Officer and Chief financial officer, Celeste Mellet, which will be followed by a Q&A session ...

According to InvestingPro analysis, Humana currently appears undervalued, with strong fundamentals including a healthy balance sheet and 15 consecutive years of dividend payments. The company ...

Health insurer Humana on Wednesday reported lower-than expected medical costs in the first quarter, allaying investor concerns about the sector after bellwether UnitedHealth's disappointing financial ...

Humana stock seems to have slowed its multi-year slide, but its valuation still lies in the doldrums. When the company reports earnings Wednesday morning, investors likely won’t focus on the past ...